Filings under TGEN by Targeted Genetics Corp (CIK 0000921114) from May 8, 2006 to Oct 12, 2009 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Deschenes Roger P. | Chief Financial Officer | Grant(A) | 29K | — | $0 |
| Jun 26, 2026 | Panora Robert | COO and President | Grant(A) | 10K | — | $0 |
| Jun 26, 2026 | Whiting John Kimball IV | General Counsel & Secretary | Grant(A) | 19K | — | $0 |
| Jun 26, 2026 | Lafaille Stephen | VP of Business Development | Grant(A) | 29K | — | $0 |
| Jun 26, 2026 | Rangesh Abinand | Chief Executive Officer, Director | Grant(A) | 174K | — | $0 |
| Jun 26, 2026 | Albertine John M | Director | Grant(A) | 25K | $5.17 | $129K |
| Jun 26, 2026 | Ghoniem Ahmed | Director | Grant(A) | 25K | $5.17 | $129K |
| Jun 26, 2026 | Galiteva Angelina | Director | Grant(A) | 25K | $5.17 | $129K |
| Jun 26, 2026 | Hirsch Susan B | Director | Grant(A) | 25K | $5.17 | $129K |
| Jun 26, 2026 | Lewis Earl | Director | Grant(A) | 25K | $5.17 | $129K |
| Apr 24, 2026 | Ghoniem Ahmed | Director | Buy(P) | 13K | $0.79 | $10K |
| Apr 24, 2026 | Ghoniem Ahmed | Director | Option exercise(M) | 13K | $0.79 | $10K |
| Apr 13, 2026 | Hirsch Susan B | Director | Buy(P) | 5K | $3.73 | $19K |
| Mar 27, 2026 | Lewis Earl | Director | Buy(P) | 5K | $2.52 | $13K |
| Mar 27, 2026 | Hirsch Susan B | Director | Buy(P) | 10K | $2.54 | $25K |
| Mar 26, 2026 | Lewis Earl | Director | Buy(P) | 5K | $2.88 | $14K |
| Mar 23, 2026 | Whiting John Kimball IV | General Counsel & Secretary | Buy(P) | 10K | $2.38 | $24K |
| Mar 20, 2026 | Hatsopoulos John | Director | Option exercise(M) | 50K | $0.88 | $44K |
| Mar 20, 2026 | Hatsopoulos John | Director | Option exercise(M) | 50K | $0.88 | $44K |
| Mar 20, 2026 | Rangesh Abinand | Chief Executive Officer, Director | Buy(P) | 3K | $2.30 | $7K |
| Mar 20, 2026 | Deschenes Roger P. | CAO | Buy(P) | 10K | $2.23 | $22K |
| Jul 24, 2025 | Galiteva Angelina | Director | Grant(A) | 25K | $8.35 | $209K |
| Jul 24, 2025 | Lewis Earl R | Director | Grant(A) | 25K | $8.35 | $209K |
| Jul 24, 2025 | Ghoniem Ahmed | Director | Grant(A) | 25K | $8.35 | $209K |
| Jul 24, 2025 | Hirsch Susan B | Director | Grant(A) | 25K | $8.35 | $209K |
| Jul 24, 2025 | Rangesh Abinand | Chief Executive Officer, Director | Grant(A) | 54K | — | $0 |
| Jul 24, 2025 | Rangesh Abinand | Chief Executive Officer, Director | Grant(A) | 12K | $8.35 | $101K |
| Jul 24, 2025 | Rangesh Abinand | Chief Executive Officer, Director | Grant(A) | 24K | $8.35 | $201K |
| Jul 24, 2025 | Deschenes Roger P. | CAO | Grant(A) | 18K | — | $0 |
| Jul 24, 2025 | Deschenes Roger P. | CAO | Grant(A) | 12K | $8.35 | $101K |
| Jul 24, 2025 | Whiting John Kimball IV | General Counsel & Secretary | Grant(A) | 12K | — | $0 |
| Jul 24, 2025 | Whiting John Kimball IV | General Counsel & Secretary | Grant(A) | 24K | $8.35 | $201K |
| Jul 24, 2025 | Lafaille Stephen | VP of Business Development | Grant(A) | 12K | — | $0 |
| Jul 24, 2025 | Lafaille Stephen | VP of Business Development | Grant(A) | 24K | $8.35 | $201K |
| Jul 24, 2025 | Albertine John M | Director | Grant(A) | 25K | $8.35 | $209K |
| Jun 24, 2025 | Panora Robert A | COO and President | Sell(S) | 900 | $6.86 | $6K |
| Jun 23, 2025 | Panora Robert A | COO and President | Sell(S) | 32K | $6.36 | $202K |
| Jun 23, 2025 | Lafaille Stephen | VP of Business Development | Sell(S) | 10K | $7.25 | $73K |
| Jun 23, 2025 | Lafaille Stephen | VP of Business Development | Option exercise(X) | 10K | $1.10 | $11K |
| Jun 23, 2025 | Lafaille Stephen | VP of Business Development | Option exercise(X) | 10K | $1.10 | $11K |
| Jun 18, 2025 | Panora Robert A | COO and President | Sell(S) | 13K | $5.03 | $65K |
| Jun 16, 2025 | Panora Robert A | COO and President | Option exercise(M) | 13K | $0.79 | $10K |
| Jun 16, 2025 | Panora Robert A | COO and President | Option exercise(M) | 30K | $0.71 | $21K |
| Jun 16, 2025 | Panora Robert A | COO and President | Option exercise(M) | 53K | $1.10 | $58K |
| Jun 16, 2025 | Panora Robert A | COO and President | Option exercise(M) | 30K | $0.71 | $21K |
| Jun 16, 2025 | Panora Robert A | COO and President | Option exercise(M) | 13K | $0.79 | $10K |
| Jun 16, 2025 | Panora Robert A | COO and President | Option exercise(M) | 53K | $1.10 | $58K |
| Jun 6, 2025 | Lafaille Stephen | VP of Business Development | Option exercise(X) | 25K | $1.10 | $28K |
| Jun 6, 2025 | Lafaille Stephen | VP of Business Development | Sell(S) | 25K | $5.98 | $150K |
| Jun 6, 2025 | Lafaille Stephen | VP of Business Development | Option exercise(X) | 25K | $1.10 | $28K |
| Jun 4, 2025 | Panora Robert A | COO and President | Sell(S) | 31K | $5.00 | $155K |
| Jun 4, 2025 | Lafaille Stephen | VP of Business Development | Option exercise(X) | 15K | $0.71 | $11K |
| Jun 4, 2025 | Lafaille Stephen | VP of Business Development | Sell(S) | 15K | $5.00 | $75K |
| Jun 4, 2025 | Lafaille Stephen | VP of Business Development | Option exercise(X) | 15K | $0.71 | $11K |
| Jun 3, 2025 | Panora Robert A | COO and President | Sell(S) | 26K | $4.69 | $122K |
| Jun 3, 2025 | Lafaille Stephen | VP of Business Development | Option exercise(X) | 10K | $0.71 | $7K |
| Jun 3, 2025 | Lafaille Stephen | VP of Business Development | Sell(S) | 10K | $4.88 | $49K |
| Jun 3, 2025 | Lafaille Stephen | VP of Business Development | Option exercise(X) | 10K | $0.71 | $7K |
| May 27, 2025 | Panora Robert A | COO and President | Option exercise(M) | 70K | $0.71 | $50K |
| May 27, 2025 | Panora Robert A | COO and President | Option exercise(M) | 70K | $0.71 | $50K |
| May 6, 2025 | Lewis Earl R | Director | Option exercise(X) | 13K | $1.20 | $15K |
| May 6, 2025 | Lewis Earl R | Director | Option exercise(X) | 15K | $1.75 | $26K |
| May 6, 2025 | Lewis Earl R | Director | Option exercise(X) | 6K | $1.10 | $7K |
| May 1, 2025 | Lewis Earl R | Director | Other(J) | 240K | $2.14 | $514K |
| Mar 3, 2025 | Lafaille Stephen | VP of Business Development | Buy(P) | 400 | $2.50 | $1K |
| Nov 22, 2024 | Lewis Earl R | Director | Option exercise(X) | 100K | $0.71 | $71K |
| Nov 22, 2024 | Lewis Earl R | Director | Option exercise(M) | 100K | $0.71 | $71K |
| Sep 27, 2024 | Hatsopoulos John | Director | Buy(P) | 10K | $0.84 | $8K |
| Sep 25, 2024 | Hatsopoulos John | Director | Buy(P) | 10K | $0.86 | $9K |
| Aug 19, 2024 | Hatsopoulos John | Director | Buy(P) | 10K | $0.90 | $9K |
| Jul 15, 2024 | Lewis Earl R | Director | Buy(P) | 10K | $0.68 | $7K |
| Jul 15, 2024 | Lewis Earl R | Director | Buy(P) | 10K | $0.68 | $7K |
| Jul 10, 2024 | Hatsopoulos John | Director | Buy(P) | 22K | $0.65 | $15K |
| Jun 6, 2024 | Lewis Earl R | Director | Grant(A) | 25K | $0.77 | $19K |
| Jun 6, 2024 | Albertine John M | Director | Grant(A) | 25K | $0.77 | $19K |
| Jun 6, 2024 | Hirsch Susan B | Director | Grant(A) | 25K | $0.77 | $19K |
| Jun 6, 2024 | Galiteva Angelina | Director | Grant(A) | 25K | $0.77 | $19K |
| Jun 6, 2024 | Ghoniem Ahmed | Director | Grant(A) | 25K | $0.77 | $19K |
| May 29, 2024 | Hatsopoulos John | Director | Buy(P) | 10K | $0.80 | $8K |
| May 28, 2024 | Hatsopoulos John | Director | Buy(P) | 1K | $0.80 | $1K |
| May 24, 2024 | Hatsopoulos John | Director | Buy(P) | 9K | $0.80 | $7K |
| May 22, 2024 | Hatsopoulos John | Director | Buy(P) | 3K | $0.79 | $3K |
| May 21, 2024 | Hatsopoulos John | Director | Buy(P) | 14K | $0.79 | $11K |
| May 16, 2024 | Hatsopoulos John | Director | Buy(P) | 3K | $0.75 | $2K |
| May 15, 2024 | Hatsopoulos John | Director | Buy(P) | 10K | $0.74 | $7K |
| May 1, 2024 | Lewis Earl R | Director | Buy(P) | 5K | $0.75 | $4K |
| Apr 24, 2024 | Hatsopoulos John | Director | Buy(P) | 5K | $0.67 | $3K |
| Apr 24, 2024 | Lewis Earl R | Director | Buy(P) | 10K | $0.68 | $7K |
| Apr 23, 2024 | Hatsopoulos John | Director | Buy(P) | 1K | $0.68 | $680 |
| Apr 23, 2024 | Hatsopoulos John | Director | Buy(P) | 5K | $0.69 | $3K |
| Apr 16, 2024 | Hatsopoulos John | Director | Buy(P) | 1K | $0.68 | $680 |
| Apr 15, 2024 | Hatsopoulos John | Director | Buy(P) | 1K | $0.70 | $700 |
| Apr 12, 2024 | Hatsopoulos John | Director | Buy(P) | 1K | $0.70 | $700 |
| Apr 11, 2024 | Hatsopoulos John | Director | Buy(P) | 1K | $0.70 | $700 |
| Apr 9, 2024 | Hatsopoulos John | Director | Buy(P) | 1K | $0.70 | $700 |
| Apr 8, 2024 | Hatsopoulos John | Director | Buy(P) | 1K | $0.70 | $700 |
| Apr 1, 2024 | Hatsopoulos John | Director | Buy(P) | 5K | $0.70 | $4K |
| Apr 1, 2024 | Hatsopoulos John | Director | Buy(P) | 612 | $0.70 | $428 |
| Mar 28, 2024 | Hatsopoulos John | Director | Buy(P) | 2K | $0.70 | $2K |
| Mar 27, 2024 | Hatsopoulos John | Director | Buy(P) | 2K | $0.70 | $1K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Tecogen Inc., SEC CIK 0001537435. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under TGEN and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-19. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for TGEN